ClinicalTrials.Veeva

Menu

Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage

I

Institut Claudius Regaud

Status and phase

Completed
Phase 3

Conditions

Vulvar Neoplasms
Skin Neoplasms

Treatments

Device: classical lymphadenectomy
Device: ultracision

Study type

Interventional

Funder types

Other

Identifiers

NCT00224744
05 DIVE 03

Details and patient eligibility

About

The purpose of this study is to evaluate the decrease of post-operative morbidity in inguinal lymphadenectomies realised for vulvar tumors and inferior limb skin tumors by use of Ultracision with regard to classical operative techniques.

Enrollment

73 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Vulvar neoplasm, inferior limb's skin malignant tumours, with an inguinal curage indication.
  • Age ≥ 18 years
  • Hematological functions : leucocytes > 1500/mm3, hemoglobin > 8 g/dl, blood platelets > 150000/mm3.
  • Well informed written consent signed by the patient
  • Negative pregnancy test for female patient of child-bearing potential.

Exclusion criteria

  • Preliminary surgery of inguinal cavity (sentinel lymph node removal accepted)
  • Massive lymph node invasion with femoro-vessels attack
  • Inclusion in another study (excepted study turned to inguinal lymph node)
  • Pregnant or nursing women
  • Patient under guardianship or trusteeship

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

73 participants in 2 patient groups

Classical surgical Inguinal curage
Active Comparator group
Description:
Classical Inguinal curage
Treatment:
Device: classical lymphadenectomy
Ultracision surgical Inguinal curage
Experimental group
Treatment:
Device: ultracision

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems